17% had LDL cholesterol <70% and 53% LDL ct <100 mg/dl. The patients at target level of LDL cholesterol were more frequently males, with more frequent CV risk factors and history of CV events, more frequent comorbidities and ≥5 drugs prescribed. The level of LDL cholesterol influenced the prescription of statins: in the group with LDL cholesterol ≥100 mg/dl, the cardiologists started, increased the dosage or changed the statin therapy in more than twofold of cases, even if only in about 30% of cases. The group of patients at target LDL cholesterol on statin therapy had the best prognosis (survival free from death and/or hospitalization 75% at 3 years). On the other hand, the group of patients with low LDL cholesterol level not on statin therapy (older with more advanced CV and not CV disease) had the worst prognosis (survival free from death and/or hospitalization 45% at 3 years, p< 0.001). Conclusions: In our population of outpatients with CAD enrolled in CVRT, the target LDL cholesterol <70 mg/dl and <100 mg/dl was reached by 17% and 53% of cases. The availability and target level of LDL cholesterol influenced the statins prescription, but there is still a large room to improve proactive cardiology intervention in very high risk patiens. The medium term outcome is strongly related to the target KEYWORDS: coronary heart disease, hyperlipemia, cholesterol, statin, secondary prevention. CITATION: Cardiol Croat. 2014;9(5-6):247.
